Vimarsana
Biggest News Aggregation in the World

Page 3 - Nasdaq Scph News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Scph. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Scph Today - Breaking & Trending Today

Maxim Group Raises scPharmaceuticals (NASDAQ:SCPH) Price Target to $20.00 - Vimarsana News

Maxim Group Raises scPharmaceuticals (NASDAQ:SCPH) Price Target to $20.00

ScPharmaceuticals (NASDAQ:SCPH – Get Rating) had its price objective lifted by Maxim Group from $13.00 to $20.00 in a research report released on Thursday morning, The Fly reports. Several other research firms have also weighed in on SCPH. HC Wainwright reissued a buy rating and set a $18.00 price objective on shares of scPharmaceuticals in […]

scPharmaceuticals (NASDAQ:SCPH) Price Target Increased to $20.00 by Analysts at Maxim Group - Vimarsana News

scPharmaceuticals (NASDAQ:SCPH) Price Target Increased to $20.00 by Analysts at Maxim Group

ScPharmaceuticals (NASDAQ:SCPH – Get Rating) had its target price boosted by equities researchers at Maxim Group from $13.00 to $20.00 in a research note issued to investors on Thursday, The Fly reports. Maxim Group’s price target would suggest a potential upside of 84.84% from the company’s previous close. Other research analysts have also issued reports […]

Source: wkrb13.com
scPharmaceuticals Inc. (NASDAQ:SCPH) Given Average Rating of "Buy" by Brokerages - Vimarsana News

scPharmaceuticals Inc. (NASDAQ:SCPH) Given Average Rating of "Buy" by Brokerages

Shares of scPharmaceuticals Inc. (NASDAQ:SCPH – Get Rating) have been assigned an average rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have issued a report on the […]

scPharmaceuticals (NASDAQ:SCPH) Given Buy Rating at HC Wainwright - Vimarsana News

scPharmaceuticals (NASDAQ:SCPH) Given Buy Rating at HC Wainwright

HC Wainwright reaffirmed their buy rating on shares of scPharmaceuticals (NASDAQ:SCPH – Get Rating) in a research note released on Thursday, Benzinga reports. HC Wainwright currently has a $18.00 target price on the stock. HC Wainwright also issued estimates for scPharmaceuticals’ FY2025 earnings at $0.12 EPS, FY2026 earnings at $1.62 EPS and FY2027 earnings at […]

scPharmaceuticals Inc. Announces Appointment of Rachael - Vimarsana News

scPharmaceuticals Inc. Announces Appointment of Rachael

Appointment brings more than 20 years of life sciences finance leadership experience to the CFO role...